Physician profile
Rakeshkumar Lakhani
NPI 1518373646
$6,287.78
in general payments reported to CMS, 2019-2025
18 companies · $877 in 2025
The $877 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,113 · 2020: $391 · 2021: $836 · 2022: $1,079 · 2023: $965 · 2024: $1,027 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,717 · Entertainment: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,716.80 |
| Entertainment | $151.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,794.40 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $854.86 | 2022-2025 | Infuse, Vyzulta, Biotrue One Day |
| Sun Pharmaceutical Industries INC. | $568.06 | 2020-2023 | Cequa |
| Alcon Vision LLC | $550.05 | 2019-2025 | Total30, Dailies, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $520.48 | 2019-2021 | |
| Coopervision INC. | $401.72 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Eyevance Pharmaceuticals LLC | $326.22 | 2019-2022 | |
| Shire North American Group INC | $197.07 | 2019 | |
| Optos, INC. | $151.99 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $136.67 | 2023 | |
| Sight Sciences, INC. | $131.25 | 2022 | |
| Maculogix, INC. | $127.16 | 2019 | |
| Harrow Eye, LLC | $125.00 | 2024 | Vevye |
| Regeneron Healthcare Solutions, INC. | $117.72 | 2020 | |
| Lkc Technologies, INC. | $99.61 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $86.47 | 2022 | |
| Rxsight INC | $76.26 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $22.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakeshkumar Lakhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.